A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease

@article{Griffiths1994ADA,
  title={A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease},
  author={Paul D. Griffiths and Robert H. Perry and Alan R. Crossman},
  journal={Neuroscience Letters},
  year={1994},
  volume={169},
  pages={68-72}
}
Autoradiography allows precise anatomical matching as well as quantification of receptor density and is an ideal procedure to investigate neurotransmitter receptor distribution. Post mortem tissue from the caudate and putamen was investigated in cases of Parkinson's disease, Alzheimer's disease and age matched controls. Autoradiography was used to determine benzodiazepine, muscarinic cholinergic, D1 and D2 dopamine receptor density in these regions. This work shows that within the control group… Expand
The cholinergic system in Alzheimer's disease
TLDR
There is evidence that the most affected areas include the cortex, the entorhinal area, the hippocampus, the ventral striatum and the basal part of the forebrain, while other brain areas are less affected. Expand
Changes in the Gene Expression of GABAA Receptor α1 and α2 Subunits and Metabotropic Glutamate Receptor 5 in the Basal Ganglia of the Rats with Unilateral 6-Hydroxydopamine Lesion and Embryonic Mesencephalic Grafts
TLDR
The data indicate the mechanism of gene regulation for the modified expression of the receptors and could implicate the participation ofThe receptors in the pathogenesis of Parkinson's disease. Expand
Caudate Nucleus Dopamine D2 Receptors in Vascular Dementia
TLDR
Caudate nucleus dopamine (DA) D2 receptors were studied in patients with vascular dementia and in a control group using [3H]raclopride as a radioligand and the binding affinity was significantly lower in the VaD group. Expand
Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride
TLDR
Results indicate long‐term downregulation of striatal dopamine D2 receptor binding in PD, which may be induced by chronic dopaminergic therapy or occur independently of treatment, as a result of structural adaptation of the postsynaptic dopamin allergic system to the progressive decline of nigrostriatal neurons. Expand
Regional distribution of benzodiazepine binding sites in the human newborn and infant hypothalamus A quantitative autoradiographic study
TLDR
Evidence is provided for a large distribution of benzodiazepine binding sites in neonate/infant hypothalamus, suggesting their implication in the development of this brain structure and the maintenance of its various functions. Expand
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease — effect of L-Dopa
TLDR
Correlations between SLI, HVA and 5-HIAA indicate a heterogenous brain disorder in PD with alterations of several transmitter systems and functions, compatible with a dysregulated synthesis and/or posttranslational processing. Expand
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease
TLDR
The hypothesis of an involvement of dopamine in AD, even in those patients with no evidence of Parkinsonism, behavioral abnormalities or psychosis, is supported. Expand
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
TLDR
The [(18)F]dopa PET findings suggest that parkin disease is associated with more severe and widespread presynaptic dopaminergic deficits, and global decreases in D2 binding found in parkin compared with YOPD patients could be a direct consequence of the parkin genetic defect itself or a greater susceptibility to receptor downregulation following long-term dopaminerential agent exposure. Expand
GABA transporters (GAT-1) in Alzheimer's disease
TLDR
The unaltered [3H]tiagabine binding to GAT-1 protein indicates that intrinsic GABA neurons are spared in Alzheimer's disease. Expand
Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders.
TLDR
The genetic bases of putamenVolume are provided and potential mechanisms whereby altered putamen volume manifests in these neuropsychiatric and neurodegenerative conditions are explored, with a specific focus on dopaminergic processes. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 17 REFERENCES
Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology
The distribution and density of dopamine D1 and D2 receptors were examined by autoradiography in postmortem brain tissue from patients with pathological diagnosis of Parkinson's disease, statusExpand
A post-mortem study on striatal dopamine receptors in Parkinson's disease
TLDR
There is a modest decline in the number of striatal dopamine D2 receptors in advanced patients with PD at the end stage of the disease, suggesting that intrinsic striatal cholinergic neurons are not affected in PD. Expand
GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease.
TLDR
It is suggested that the decreased density of GABAA receptor in PD brains reflects degeneration of neurons on which the receptor is localized, i.e., degenerationof ascending monoaminergic neurons including nigral dopamine (DA) neurons. Expand
Mapping dopamine receptors in the human brain.
TLDR
A marked age-dependent decline in the density of D1 receptors during the first decades of life is observed, while D2 receptor concentrations appeared to be unaltered with age, and no significant differences in density and distribution were seen for either D1 nor D2 receptors. Expand
Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases
TLDR
Although comparable alterations of various cholinergic markers are observed in cortical areas in the three neurological disorders investigated in the present study, important differences are seen in subcortical areas. Expand
D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis
TLDR
The distribution of dopamine D-1 receptors has been determined in the rat brain by a quantitative in vitro light-microscopic autoradiographic method and the results suggest possible CNS sites of action of D- 1 dopamine receptor selective compounds. Expand
Heterogeneous distribution of benzodiazepine receptors in the human striatum: a quantitative autoradiographic study comparing the pattern of receptor labelling with the distribution of acetylcholinesterase staining
The distribution of benzodiazepine receptors in the human striatum was studied by quantitative autoradiography following in vitro labelling of cryostat sections with [3H]flunitrazepam, and theExpand
Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
TLDR
The uneven reduction of dopamine and serotonin appears to preclude the possibility of a defect in the transport of precursor amino-acids into brain and in the synthesis, storage, and degradation of the monoamines in Parkinson's disease. Expand
Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies
TLDR
The distribution and characteristics of M1 and M2 muscarinic cholinergic receptors as defined by their affinity for the antagonist pirenzepine were studied in the human brain using in vitro quantitative autoradiographic techniques, showing a differential anatomical distribution comparable to that observed in the rat brain. Expand
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia
TLDR
Changes in [3H]QNB binding and choline acetyltransferase activity were studied in post-mortem brains from control and Parkinsonian subjects in relation to dementia and mental disturbances following anticholinergic treatment frequently observed in Parkinson's disease. Expand
...
1
2
...